BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hamai Y, Emi M, Ibuki Y, Murakami Y, Nishibuchi I, Nagata Y, Furukawa T, Kurokawa T, Ohsawa M, Yoshikawa T, Okada M. Predictions of Pathological Features and Recurrence Based on FDG-PET Findings of Esophageal Squamous Cell Carcinoma after Trimodal Therapy. Ann Surg Oncol 2020;27:4422-30. [PMID: 32405978 DOI: 10.1245/s10434-020-08609-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Hamai Y, Emi M, Ibuki Y, Murakami Y, Nishibuchi I, Nagata Y, Kurokawa T, Yoshikawa T, Hirohata R, Ohsawa M, Kitasaki N, Okada M. Prognostic value of quantitative parameters for esophageal squamous cell carcinoma determined by preoperative FDG-PET after trimodal therapy. Surgery 2022. [DOI: 10.1016/j.surg.2022.03.034] [Reference Citation Analysis]
2 Murakami Y, Kawahara D, Tani S, Kubo K, Katsuta T, Imano N, Takeuchi Y, Nishibuchi I, Saito A, Nagata Y. Predicting the Local Response of Esophageal Squamous Cell Carcinoma to Neoadjuvant Chemoradiotherapy by Radiomics with a Machine Learning Method Using 18F-FDG PET Images. Diagnostics (Basel) 2021;11:1049. [PMID: 34200332 DOI: 10.3390/diagnostics11061049] [Reference Citation Analysis]
3 Hirohata R, Hamai Y, Emi M, Kurokawa T, Yoshikawa T, Ohsawa M, Tadokoro K, Okada M. Prediction of the tumor response and survival based on computed tomography in esophageal squamous cell carcinoma after trimodality therapy. Surg Today 2021;51:1496-505. [PMID: 33797639 DOI: 10.1007/s00595-021-02277-7] [Reference Citation Analysis]